Trial Outcomes & Findings for TPN-Induced Hyperglycemia: Impact on Clinical Outcome in Intensive Care Unit (ICU) and Non-ICU Patients (NCT NCT00604669)
NCT ID: NCT00604669
Last Updated: 2013-12-13
Results Overview
Mortality rate of those with hyperglycemia while on TPN duing the period of 1/01/06 to 12/31/06.
Recruitment status
COMPLETED
Target enrollment
170 participants
Primary outcome timeframe
at the end of the chart review of all patients
Results posted on
2013-12-13
Participant Flow
170 charts reviewed
Nothing to disclose.
Participant milestones
| Measure |
Those Exposed to TPN
|
|---|---|
|
Overall Study
STARTED
|
170
|
|
Overall Study
COMPLETED
|
163
|
|
Overall Study
NOT COMPLETED
|
7
|
Reasons for withdrawal
| Measure |
Those Exposed to TPN
|
|---|---|
|
Overall Study
lack of information in chart
|
7
|
Baseline Characteristics
TPN-Induced Hyperglycemia: Impact on Clinical Outcome in Intensive Care Unit (ICU) and Non-ICU Patients
Baseline characteristics by cohort
| Measure |
Those Exposed to TPN
n=163 Participants
|
|---|---|
|
Age, Categorical
<=18 years
|
4 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
120 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
39 Participants
n=5 Participants
|
|
Age, Continuous
|
60 years
STANDARD_DEVIATION 17 • n=5 Participants
|
|
Sex: Female, Male
Female
|
57 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
106 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
163 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: at the end of the chart review of all patientsMortality rate of those with hyperglycemia while on TPN duing the period of 1/01/06 to 12/31/06.
Outcome measures
| Measure |
Those Exposed to TPN
n=163 Participants
|
|---|---|
|
Mortality
|
36 mortality rate
|
Adverse Events
Those Exposed to TPN
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place